Skip to main content
. 2021 Dec 14;12:802942. doi: 10.3389/fphar.2021.802942

FIGURE 1.

FIGURE 1

Treatment sequences used in the model. (A) Treatment sequence for patients who receive pembrolizumab in the first-line setting. (B) Treatment sequence for patients who receive pembrolizumab in the second-line setting. (C) Treatment sequence for patients who receive chemotherapy.